Rennova Health (RNVA) Reports Q2 Loss of $0.40/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St set for higher open tech gains offset bond-market jitters
- Oil prices rise 2% as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- Alphabet shares up in premarket trade after Gemini 4 Argon launch
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Rennova Health Reports Second Quarter 2016 Financial Results
August 15, 2016 8:31 AM EDTConference call begins at 11:00 a.m. Eastern time today
WEST PALM BEACH, Fla.--(BUSINESS WIRE)-- Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software (Rennova or the Company), reports financial results for the three and six months ended June 30, 2016, and provides a business update.
Business highlights for the second quarter of 2016 and recent weeks include:
Converted approximately $2.0 million of liabilities into equity in August 2016 Signed an agreement... More